Webinar: Recursion Trial Update with Chris Gibson, Ph.D.
Mark your calendars for March 6 at 7:00 PM ET as we welcome Recursion CEO Chris Gibson to share an exciting update on the REC-994 clinical trial. The REC-994 Phase 2 trial was the first industry-sponsored clinical trial specifically for CCM. You'll learn firsthand about the progress being made toward a potential treatment for cavernous...